Raj Manchanda
Chief Tech/Sci/R&D Officer at NEUMORA THERAPEUTICS, INC.
Raj Manchanda active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-06-30 | - |
Career history of Raj Manchanda
Former positions of Raj Manchanda
| Companies | Position | Start | End |
|---|---|---|---|
| Anokion US, Inc. | Corporate Officer/Principal | 2019-04-30 | 2023-06-30 |
| KORRO BIO, INC. | Corporate Officer/Principal | 2016-01-31 | 2018-09-30 |
Training of Raj Manchanda
| Yale University | Doctorate Degree |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Frequency Therapeutics, Inc.
 Frequency Therapeutics, Inc. BiotechnologyHealth Technology Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the business of developing therapeutics to activate a person's innate regenerative potential to restore function. The firm is also involved in creating and commercializing therapeutics to potentially transform the lives of individuals by repairing or reversing damage done to cells, tissue, and organs. The company was founded by Robert S. Langer, David L. Lucchino, Christopher R. Loosey, and Will J. McLean on November 13, 2014 and is headquartered in Lexington, MA. | Health Technology |
| Anokion US, Inc. |
- Stock Market
- Insiders
- Raj Manchanda
- Experience
